Reuters

Novo Nordisk to submit interim data on Tresiba drug in U.S.

March 26 (Reuters) - Denmark's Novo Nordisk said on Thursday it had decided to submit interim analysis data from a clinical trial of its crucial new insulin drug Tresiba to U.S. regulators within the ...

Novo Nordisk slashes U.S. list prices for insulin meds Tresiba, Fiasp

Novo Nordisk said it will cut the list prices in the U.S. of two of its insulin drugs, Tresiba (insulin degludec) and Fiasp ...
The Business Journals

Novo can't shake Express Scripts' 'non-preferred' status for diabetes drug

New studies on the effectiveness of Novo Nordisk's newest insulin have not been enough to convince Express Scripts to give it preferred status on its formulary. New studies on the effectiveness of ...
Reuters

US FDA staff flags risk of low blood sugar for Novo Nordisk's weekly insulin

May 22 (Reuters) - The U.S. Food and Drug Administration's staff said on Wednesday the use of Novo Nordisk's (NOVOb.CO), opens new tab long-acting weekly insulin had an increased risk of low blood ...

Gavin Newsom announces plan to sell affordable, state-branded insulin next year

Gov. Gavin Newsom said Thursday that California will begin selling affordable insulin under its own label on Jan. 1, nearly three years after he first announced a partnership to sell state-branded ...